Log in

FirstLoad 6/5/2026 8:43:45 PM

FirstLoadOrReset 6/5/2026 8:43:45 PM

LastRefresh 6/5/2026 8:43:45 PM

NextRefresh 6/5/2026 8:44:45 PM

QuestionSession 6/5/2026 9:28:45 PM

EndSession 6/5/2026 9:43:45 PM

ShowRefreshModal False

AllSet True

I forgot my username or password

Get in touch with us at Spiral if you would like to see more of our software [email protected]

About the trial

The T1D-Plus trial forms part of a collection of clinical studies that come under the umbrella of the INNODIA group.

It has a new kind of design called an “adaptive platform trial” aiming to test several different treatments for their ability to preserve beta cell function relative to a control treatment.

The people behind the software

We are rethinking research tools, globally. That means we can adapt our existing platform to match new ways of thinking—building capacity in support of your existing clinical practices!

Complex trials require dependable solutions. Our flagship product, Spinnaker (this is it), offers you a comprehensive solution that covers all your trial management needs. From stock control and audit log to reporting, user management and compliance – we tailor the platform exactly as you need it for your study. Designed and coded by our expert team, we ensure complete control over configuration and setup. Experience the perfect blend of adaptability and precision with Spinnaker.

You can read more on the Spiral website or contact us on [email protected]

You can get to know us a little better through our blog and social media pages accessed via the logout screen of this trial.

Made with love in New Zealand.